Celebrating 20 Years of Training in Botox®, Aesthetic Medicine
and Medical Weight Management

Start Training Now
IAPAM Logo
Register Your Team Now

SPRING SPECIAL

Register your team for any available 2026 dates for hands-on Botox training & GLP-1 for Weight Loss training at the Aesthetic Medicine Symposium and save up to 30%!

Registration Deadline: May 15, 2026

Celebrating 20 Years of Excellence in Botox®, Aesthetic Medicine & Medical Weight Management Training & Certification

IAPAM Logo

Save up to 30% on hands-on Botox® or GLP-1 team training packages at the Aesthetic Medicine Symposium! Register before May 15!

Register Your Team
Home »Botox® Library » Botox® vs Other Injectables: a Comparative History

Botox® vs Other Injectables: a Comparative History

The field of medical aesthetics has evolved dramatically over the past few decades, transforming the way individuals and clinics approach minimally invasive cosmetic procedures. Among the most well-known treatments is Botox® (onabotulinumtoxinA), a household name that has shaped much of the aesthetics landscape since its introduction. However, Botox® is certainly not alone—an array of injectable products, each offering unique benefits, have broadened the options for patients and practitioners alike.

botox vs other injectables

Understanding the comparative history of Botox® vs other injectables is crucial for both clinic owners seeking the best solutions for their clients and consumers eager to make informed choices.

We’ll take a look at the origins, clinical implications, and differences between Botox® and other injectable alternatives such as Dysport®, Xeomin®, Jeuveau™, as well as dermal fillers like Juvederm®, Restylane®, and others. Whether you are a medical aesthetic professional or a consumer interested in the latest advancements, this guide provides insights into why these products emerged, how they are used, and what sets them apart.

Key Takeaways Botox® vs Other Injectables

  • Botox® was the first botulinum toxin product approved for cosmetic use, revolutionizing non-surgical aesthetic treatments and setting the stage for competitors and alternatives.
  • Other neurotoxins such as Dysport®, Xeomin®, and Jeuveau™ have since entered the market, each with unique molecular properties, onset times, and clinical uses.
  • Dermal fillers, which serve different purposes than Botox®, were developed to address volume loss and facial contours, expanding the versatility of injectable treatments.
  • Understanding the historical context and differences between Botox® and other injectables empowers clinics and consumers to make better choices tailored to their goals and expectations.

The Rise of Botox®: A Groundbreaking Innovation

The story of Botox® begins in the late 20th century, when it was first used for therapeutic purposes to treat muscle spasms and various neuromuscular disorders. Derived from botulinum toxin type A, Botox® was originally intended to manage conditions such as blepharospasm (uncontrollable blinking), strabismus (crossed eyes), and cervical dystonia (involuntary neck muscle contractions). In 1989, Botox® received its first FDA approval for these medical indications.

Its aesthetic potential was discovered somewhat serendipitously by Canadian ophthalmologist Dr. Jean Carruthers and her husband, dermatologist Dr. Alastair Carruthers, in the late 1980s. They noted that patients treated with Botox® for muscle spasms experienced a smoothing of worry lines between the eyebrows—ushering in a new era of cosmetic injectables. In 2002, the FDA approved Botox® for cosmetic use to temporarily improve the appearance of moderate to severe glabellar lines (frown lines between the eyebrows).

Are you a healthcare provider eager to offer Botox in your practice? Get certified through our practical, dermatologist-led Botox training course.

Hands-on Botox training

Learn to Build a Profitable Aesthetics Practice in Just 4-Days!

June 5-8, 2026
in sunny Scottsdale, AZ

Gain the Confidence & Clarity You Need to Succeed

Learn to build a profitable aesthetic practice in just 4-days!

June 5-8, 2026
Scottsdale, AZ

Save up to $3,605 when you register for all 4-days!
Register Now

*Prices advertised are preferred member pricing. Membership is $295/yr and can be added during the registration process to access the discounted pricing. 

Timeline: FDA Approvals of Major Injectables

Year Product (Brand) Type Key Milestone
1989 Botox® Neurotoxin FDA-approved (medical use)
2002 Botox® Neurotoxin FDA-approved (cosmetic use)
2003 Restylane® Hyaluronic Acid Filler FDA-approved
2006 Juvederm® Hyaluronic Acid Filler FDA-approved
2009 Dysport® Neurotoxin FDA-approved
2011 Xeomin® Neurotoxin FDA-approved
2019 Jeuveau™ Neurotoxin FDA-approved

The Era of Alternatives: Dysport®, Xeomin®, and Jeuveau™

The overwhelming success and demand for Botox® prompted other manufacturers to create alternative formulations of botulinum toxin type A. Each subsequent neurotoxin brought subtle distinctions in protein size, molecular structure, diffusion, and clinical performance.

Dysport®

Introduced in Europe in the early 1990s and FDA-approved in the U.S. in 2009, Dysport® (abobotulinumtoxinA) is known for its slightly quicker onset and broader diffusion compared to Botox®. Clinics and practitioners may choose Dysport® for certain areas of the face or for patients who have developed resistance or suboptimal response to Botox®.

Xeomin®

FDA-approved in 2011, Xeomin® (incobotulinumtoxinA) is distinguished by its “naked” formulation, containing no accessory proteins. This feature makes it a preferred option for patients who may develop immune responses to other neurotoxin products.

Jeuveau™

The newest of the major neurotoxins in North America, Jeuveau™ (prabotulinumtoxinA-xvfs) was FDA-approved in 2019. Marketed as a “Newtox”, it targets a younger demographic and is packaged with a contemporary image, though its clinical effects are similar to those of Botox®.

Beyond Wrinkles: The Emergence of Dermal Fillers

Botox®/Neurotoxins Dermal Fillers
Mechanism: Relaxes muscles Mechanism: Adds/lifts volume
Main Target: Dynamic wrinkles (expression lines: frown, crow’s feet, forehead) Main Target: Static wrinkles, thin lips, volume loss, facial contours
Onset: 3–7 days Onset: Immediate
Duration: 3–4 months (typically) Duration: 6–18 months (depends on type/location)
Examples: BOTOX®, Dysport®, Xeomin®, Jeuveau™ Examples: Juvederm®, Restylane®, Belotero®
Other Notes: Off-label uses: migraines, sweat, muscle contouring Other Notes: Different fillers for lips, cheeks, midface, jawline, chin

While Botox® and similar neurotoxins primarily address dynamic wrinkles by relaxing underlying muscles, dermal fillers emerged to target volume loss, static wrinkles, and facial contours. The first filler, bovine collagen, was introduced in the early 1980s but had limitations such as short longevity and allergy risk. The development of hyaluronic acid-based fillers like Juvederm® and Restylane® by the early 2000s revolutionized the field, offering longer-lasting, safer, and more natural-looking results.

Today, clinics can choose from a wide range of fillers to address different areas, from lips and cheeks to deep nasolabial folds and even non-surgical rhinoplasty. Fillers and toxins are frequently used together as part of comprehensive “liquid facelift” strategies.

Comparing Clinical Uses and Patient Outcomes

  • Botox® and other neurotoxins: Best for expression lines—crow’s feet, frown lines, and forehead wrinkles.
  • Fillers: Add volume, redefine contours, and correct deeper static lines.
  • Alternative toxins: Offer options for patients who may not respond optimally to Botox® or who prefer different onset times and effects.
  • The synergy of Botox® with fillers: Allows for tailored, patient-specific aesthetic plans.

Major Injectables at a Glance

Product Unique Feature Typical Uses Pros Cons
Botox® Original neurotoxin brand Forehead, eyes, glabella Trusted, versatile Temporary, repeat needed
Dysport® Diffuses slightly more; faster onset Larger areas, broader coverage Good for forehead, quick results Can “spread” more
Xeomin® No complexing proteins (“naked”) Allergic/repeat patients Less risk of antibody formation Subtle differences
Jeuveau™ Marketed as “Newtox” Similar to BOTOX® Modern branding, similar efficacy Newer, less long-term data
Juvederm® Smooth hyaluronic acid gel Nasolabial folds, cheeks, lips Long-lasting, natural feel Swelling, bruising possible
Restylane® Firmer HA gel, versatile Lips, cheeks, tear troughs Range of products, tried and tested Temporary
Others
(e.g., Sculptra™, Radiesse®)		 Deeper volume, collagen boost Longevity, collagen stimulation Not reversible (non-HA)

Future Outlook: Innovation and Patient-Centered Care

The medical aesthetic field is rapidly innovating, with new products and techniques emerging every year. Biosimilar botulinum toxins and novel cross-linked hyaluronic acid fillers are in the pipeline. Clinics that stay informed on comparative history and ongoing advances can better counsel clients and deliver the best outcomes.

Patients, in turn, benefit from understanding the unique history, differences, and scientific merits of Botox® vs other injectables—enabling educated choices that align with personal goals and expectations.

Conclusion: Botox® as a Pillar of US Aesthetics

The story of Botox® and its injectable competitors is one of scientific discovery, patient demand, and continuous evolution. For medical aesthetic clinics and consumers alike, understanding this comparative history informs safer, more effective, and more satisfying treatments. As technology and knowledge move forward, the future for injectables in medical aesthetics looks promising, offering ever more opportunities to combine science, skill, and artistry in the pursuit of natural, individualized beauty.

Disclaimer: The information provided here is for general knowledge only and should not be considered medical advice. For any questions or concerns about your health or medications, please consult your physician or healthcare provider. They are best equipped to provide guidance specific to your medical needs.

Related Articles

Hands-On BOTOX® Training in Scottsdale, Arizona
Gain the Confidence to Start Seeing Patients Right Away!

Attend the most comprehensive accredited AMA PRA CAT 1 CME Botox® training weekend, learn how to create a profitable practice with the top 5 most lucrative non-invasive treatments.

Add-on GLP-1 agonists for weight loss and/or business for 4-days of comprehensive, fun CME-accredited training like none other! 

Hands-on Botox® Training for Physicians

Hands-on Botox® injection training is done in a clean multi-million dollar medspa, NOT in a hotel. We provide live models and product, you show up and enjoy the weekend with our expert instructors!

June 5-8, 2026

Scottsdale, Arizona 

Register Now

Save $3,605 when you become an IAPAM member and register to attend all 4-days!